GenomeNet

Database: UniProt
Entry: PUR8_BACSU
LinkDB: PUR8_BACSU
Original site: PUR8_BACSU 
ID   PUR8_BACSU              Reviewed;         431 AA.
AC   P12047;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   27-MAR-2024, entry version 169.
DE   RecName: Full=Adenylosuccinate lyase;
DE            Short=ASL;
DE            EC=4.3.2.2 {ECO:0000269|PubMed:15182182};
DE   AltName: Full=Adenylosuccinase;
DE            Short=ASase;
DE   AltName: Full=Glutamyl--tRNA ligase regulatory factor;
GN   Name=purB; Synonyms=purE; OrderedLocusNames=BSU06440;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3036807; DOI=10.1016/s0021-9258(18)47560-6;
RA   Ebbole D.J., Zalkin H.;
RT   "Cloning and characterization of a 12-gene cluster from Bacillus subtilis
RT   encoding nine enzymes for de novo purine nucleotide synthesis.";
RL   J. Biol. Chem. 262:8274-8287(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-30.
RC   STRAIN=168 / BGSC1A1;
RX   PubMed=1608947; DOI=10.1073/pnas.89.12.5389;
RA   Gendron N., Breton R., Champagne N., Lapointe J.;
RT   "Adenylosuccinate lyase of Bacillus subtilis regulates the activity of the
RT   glutamyl-tRNA synthetase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:5389-5392(1992).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND MUTAGENESIS OF HIS-89; HIS-141;
RP   GLN-212; ASN-270 AND ARG-301.
RX   PubMed=15182182; DOI=10.1021/bi0494774;
RA   Segall M.L., Colman R.F.;
RT   "Gln212, Asn270, and Arg301 are critical for catalysis by adenylosuccinate
RT   lyase from Bacillus subtilis.";
RL   Biochemistry 43:7391-7402(2004).
RN   [5]
RP   SUBUNIT.
RX   PubMed=18237141; DOI=10.1021/bi701400c;
RA   De Zoysa Ariyananda L., Colman R.F.;
RT   "Evaluation of types of interactions in subunit association in Bacillus
RT   subtilis adenylosuccinate lyase.";
RL   Biochemistry 47:2923-2934(2008).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS).
RX   PubMed=10926519; DOI=10.1006/jmbi.2000.3970;
RA   Toth E.A., Worby C., Dixon J.E., Goedken E.R., Marqusee S., Yeates T.O.;
RT   "The crystal structure of adenylosuccinate lyase from Pyrobaculum
RT   aerophilum reveals an intracellular protein with three disulfide bonds.";
RL   J. Mol. Biol. 301:433-450(2000).
CC   -!- FUNCTION: Catalyzes two reactions in de novo purine nucleotide
CC       biosynthesis. Catalyzes the breakdown of 5-aminoimidazole- (N-
CC       succinylocarboxamide) ribotide (SAICAR or 2-[5-amino-1-(5-phospho-beta-
CC       D-ribosyl)imidazole-4-carboxamido]succinate) to 5-aminoimidazole-4-
CC       carboxamide ribotide (AICAR or 5-amino-1-(5-phospho-beta-D-
CC       ribosyl)imidazole-4-carboxamide) and fumarate, and of adenylosuccinate
CC       (ADS or N(6)-(1,2-dicarboxyethyl)-AMP) to adenosine monophosphate (AMP)
CC       and fumarate (PubMed:15182182). Influences the affinity of glutamyl--
CC       tRNA ligase for its substrates and increases its thermostability.
CC       {ECO:0000269|PubMed:15182182}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-(1,2-dicarboxyethyl)-AMP = AMP + fumarate;
CC         Xref=Rhea:RHEA:16853, ChEBI:CHEBI:29806, ChEBI:CHEBI:57567,
CC         ChEBI:CHEBI:456215; EC=4.3.2.2;
CC         Evidence={ECO:0000269|PubMed:15182182};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16854;
CC         Evidence={ECO:0000305|PubMed:15182182};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S)-2-[5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-
CC         carboxamido]succinate = 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide + fumarate; Xref=Rhea:RHEA:23920,
CC         ChEBI:CHEBI:29806, ChEBI:CHEBI:58443, ChEBI:CHEBI:58475; EC=4.3.2.2;
CC         Evidence={ECO:0000269|PubMed:15182182};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23921;
CC         Evidence={ECO:0000305|PubMed:15182182};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway; AMP
CC       from IMP: step 2/2.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5-
CC       amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-
CC       phospho-D-ribosyl)imidazole-4-carboxylate: step 2/2.
CC   -!- SUBUNIT: Homotetramer. Residues from neighboring subunits contribute
CC       catalytic and substrate-binding residues to each active site.
CC       {ECO:0000269|PubMed:15182182, ECO:0000269|PubMed:18237141}.
CC   -!- SIMILARITY: Belongs to the lyase 1 family. Adenylosuccinate lyase
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02732; AAA22676.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB12464.1; -; Genomic_DNA.
DR   PIR; C29326; WZBSDS.
DR   RefSeq; NP_388526.1; NC_000964.3.
DR   RefSeq; WP_003233955.1; NZ_JNCM01000032.1.
DR   PDB; 1F1O; X-ray; 3.25 A; A=1-431.
DR   PDBsum; 1F1O; -.
DR   AlphaFoldDB; P12047; -.
DR   SMR; P12047; -.
DR   IntAct; P12047; 3.
DR   MINT; P12047; -.
DR   STRING; 224308.BSU06440; -.
DR   PaxDb; 224308-BSU06440; -.
DR   EnsemblBacteria; CAB12464; CAB12464; BSU_06440.
DR   GeneID; 83883906; -.
DR   GeneID; 936048; -.
DR   KEGG; bsu:BSU06440; -.
DR   PATRIC; fig|224308.179.peg.700; -.
DR   eggNOG; COG0015; Bacteria.
DR   InParanoid; P12047; -.
DR   OrthoDB; 9768878at2; -.
DR   PhylomeDB; P12047; -.
DR   BioCyc; BSUB:BSU06440-MONOMER; -.
DR   BRENDA; 4.3.2.2; 658.
DR   SABIO-RK; P12047; -.
DR   UniPathway; UPA00074; UER00132.
DR   UniPathway; UPA00075; UER00336.
DR   EvolutionaryTrace; P12047; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0070626; F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity; IBA:GO_Central.
DR   GO; GO:0004018; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity; IDA:MGI.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006167; P:AMP biosynthetic process; IDA:MGI.
DR   CDD; cd01360; Adenylsuccinate_lyase_1; 1.
DR   Gene3D; 1.10.40.30; Fumarase/aspartase (C-terminal domain); 1.
DR   Gene3D; 1.20.200.10; Fumarase/aspartase (Central domain); 1.
DR   Gene3D; 1.10.275.10; Fumarase/aspartase (N-terminal domain); 1.
DR   InterPro; IPR019468; AdenyloSucc_lyase_C.
DR   InterPro; IPR024083; Fumarase/histidase_N.
DR   InterPro; IPR020557; Fumarate_lyase_CS.
DR   InterPro; IPR000362; Fumarate_lyase_fam.
DR   InterPro; IPR022761; Fumarate_lyase_N.
DR   InterPro; IPR008948; L-Aspartase-like.
DR   InterPro; IPR004769; Pur_lyase.
DR   NCBIfam; TIGR00928; purB; 1.
DR   PANTHER; PTHR43172; ADENYLOSUCCINATE LYASE; 1.
DR   PANTHER; PTHR43172:SF1; ADENYLOSUCCINATE LYASE; 1.
DR   Pfam; PF10397; ADSL_C; 1.
DR   Pfam; PF00206; Lyase_1; 1.
DR   PRINTS; PR00145; ARGSUCLYASE.
DR   PRINTS; PR00149; FUMRATELYASE.
DR   SMART; SM00998; ADSL_C; 1.
DR   SUPFAM; SSF48557; L-aspartase-like; 1.
DR   PROSITE; PS00163; FUMARATE_LYASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Lyase; Purine biosynthesis;
KW   Reference proteome.
FT   CHAIN           1..431
FT                   /note="Adenylosuccinate lyase"
FT                   /id="PRO_0000137873"
FT   ACT_SITE        141
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   ACT_SITE        262
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         4..5
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         67..69
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         93..94
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         212
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         263
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         268..270
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         276
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         307..311
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   MUTAGEN         89
FT                   /note="H->Q: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:15182182"
FT   MUTAGEN         141
FT                   /note="H->Q: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:15182182"
FT   MUTAGEN         212
FT                   /note="Q->E: Decreases catalytic activity 1000-fold."
FT                   /evidence="ECO:0000269|PubMed:15182182"
FT   MUTAGEN         212
FT                   /note="Q->M: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:15182182"
FT   MUTAGEN         270
FT                   /note="N->D,L: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:15182182"
FT   MUTAGEN         301
FT                   /note="R->K,Q: Abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:15182182"
FT   CONFLICT        5
FT                   /note="Y -> K (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   431 AA;  49485 MW;  89D2ED7F7F6D46A2 CRC64;
     MIERYSRPEM SAIWTDENRF QAWLEVEILA CEAWAELGVI PKEDVKVMRE NASFDINRIL
     EIEKDTRHDV VAFTRAVSES LGEERKWVHY GLTSTDVVDT ALSYLLKQAN DILLKDLERF
     VDIIKEKAKE HKYTVMMGRT HGVHAEPTTF GLKLALWHEE MKRNLERFKQ AKAGIEVGKI
     SGAVGTYANI DPFVEQYVCE KLGLKAAPIS TQTLQRDRHA DYMATLALIA TSIEKFAVEI
     RGLQKSETRE VEEFFAKGQK GSSAMPHKRN PIGSENMTGM ARVIRGYMMT AYENVPLWHE
     RDISHSSAER IILPDATIAL NYMLNRFSNI VKNLTVFPEN MKRNMDRTLG LIYSQRVLLA
     LIDTGLTREE AYDTVQPKAM EAWEKQVPFR ELVEAEEKIT SRLSPEKIAD CFDYNYHLKN
     VDLIFERLGL A
//
DBGET integrated database retrieval system